Literature DB >> 31516759

Comparison of a clinical-laboratory algorithm, 4t and heparin-induced thrombocytopenia expert probability scores in the diagnosis of heparin-induced thrombocytopenia in the critical care setting.

Moustafa Younis1, Lina Ya'qoub1, Zafar Ali1, Punita Grover1, Rawan Ya'acoub2, Majdi S Hamarshi1.   

Abstract

BACKGROUND: Several scoring systems are utilized to calculate the pre-test probability of heparin-induced thrombocytopenia (HIT). We hypothesize that a clinical-laboratory algorithm combining the 4Ts score with the optical density (OD) of anti-PF4-heparin antibody is more accurate than either the 4Ts or HIT expert probability (HEP) scores in the critical care setting.
METHODS: A single-institution retrospective review of adult patients admitted to the intensive care unit (ICU) that were evaluated for HIT was conducted. Two reviewers independently rated the proposed algorithm, 4Ts and HEP score. Summary, univariate and area under receiver operator characteristic analyses were performed.
RESULTS: A total of 88 patients with a mean (SD) age of 62 (15) years were included. The sensitivity, positive predictive value and negative predictive value were superior in our clinical-laboratory algorithm compared to the 4Ts score ≥ 4 and the HEP score ≥ 2. The algorithm's specificity was non-inferior to the 4Ts score and HEP score. There was no significant difference between our clinical-laboratory algorithm and the 4Ts score or the HEP score in predicting HIT.
CONCLUSION: Our study confirms that the combination of clinical and laboratory criteria is crucial in the presumable diagnosis of HIT. This is the first study that validates different HIT scores in an isolated ICU population.

Entities:  

Keywords:  4Ts score; HEP score; HIT; algorithms

Year:  2019        PMID: 31516759      PMCID: PMC6737338     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  1 in total

Review 1.  Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.

Authors:  Emmanuel J Favaloro; Leonardo Pasalic; Giuseppe Lippi
Journal:  Antibodies (Basel)       Date:  2022-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.